Binacea Pharma, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors (NCT05150457) | Binacea Pharma, Inc. | 2022-02-08 |
Track Binacea Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.